- Reauthorization of the Over the Counter Monograph User Fee Act - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule - FDA Modernization Act 3.0
2025 · 1st Quarter (Jan 1 - Mar 31)
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
Filed by CONSUMER HEALTHCARE PRODUCTS ASSOCIATION.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 15, 2025
- Income
- $201,227.00
- Expenses
- Not reported
- Registrant
- CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
- Filing UUID
- 8be03bc0-0ca4-4516-967b-4a31157731c9
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
- The Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act
- The SHOP SAFE Act
- H.R. 1219, Oral Health Products Inclusion Act - Pharmaceutical Tariffs - HSA/FSA Treatment for Dietary Supplements - Modernization of the Dietary Safety, Health and Education Act (DSHEA) - Regulation of Cannabidiol (CBD)
Literal federal measure citations: H.R. 1219
- Pharmaceutical Tariffs
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.